Literature DB >> 9218613

Roles of CD9 molecules in survival and activation of human eosinophils.

J T Kim1, G J Gleich, H Kita.   

Abstract

CD9 is a cell surface glycoprotein belonging to the transmembrane 4 superfamily. In this report, we demonstrate that cross-linking CD9 with different forms of mAb activates distinct functions of human eosinophils. Anti-CD9 mAb (clone ALB6) immobilized onto tissue culture plates induced eosinophil degranulation. This effect of anti-CD9 mAb (clone ALB6) was unique because other immobilized clones of anti-CD9 mAb (clones FMC56 and ML13) or anti-HLA Class I mAb failed to induce degranulation. In addition, neutrophil degranulation was not provoked by the immobilized clone ALB6, consistent with a lack of expression of CD9 on neutrophils. Eosinophil degranulation induced by anti-CD9 mAb (clone ALB6) was abolished by pretreatment of eosinophils with anti-CD18 mAb, suggesting that beta2 integrins are involved in the reaction. In contrast to the results with immobilized clones, all clones of anti-CD9 mAb in soluble form enhanced eosinophil survival. This enhanced survival was inhibited by anti-granulocyte-macrophage-CSF (GM-CSF) mAb, suggesting that autocrine production of GM-CSF by eosinophils mediated the enhanced survival. In fact, by ELISA and RT-PCR, GM-CSF protein and mRNA were detected in supernatants and cell lysates of eosinophils stimulated by soluble anti-CD9 mAb, but not by immobilized mAb. These results indicate that CD9 serves as a molecule that delivers stimulation signals on eosinophils. The eosinophil's cellular responses may differ and be dependent on the manner of receptor ligation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9218613

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Antibody cross-linking of human CD9 and the high-affinity immunoglobulin E receptor stimulates secretion from transfected rat basophilic leukaemia cells.

Authors:  A Higginbottom; I Wilkinson; B McCullough; F Lanza; D O Azorsa; L J Partridge; P N Monk
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

2.  The impact of eotaxin- and IL-5-induced adhesion and transmigration on eosinophil activity markers.

Authors:  E Fernvik; J Lundahl; G Halldén
Journal:  Inflammation       Date:  2000-02       Impact factor: 4.092

3.  MHC Class II and CD9 in human eosinophils localize to detergent-resistant membrane microdomains.

Authors:  Praveen Akuthota; Rossana C N Melo; Lisa A Spencer; Peter F Weller
Journal:  Am J Respir Cell Mol Biol       Date:  2011-09-01       Impact factor: 6.914

4.  Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7.

Authors:  Nicodemus Tedla; Christianne Bandeira-Melo; Paolo Tassinari; David E Sloane; Mary Samplaski; David Cosman; Luis Borges; Peter F Weller; Jonathan P Arm
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-14       Impact factor: 11.205

5.  Eosinophils in the blood of hematopoietic stem cell transplanted patients are activated and have different molecular marker profiles in acute and chronic graft-versus-host disease.

Authors:  Julia Cromvik; Marianne Johnsson; Krista Vaht; Jan-Erik Johansson; Christine Wennerås
Journal:  Immun Inflamm Dis       Date:  2014-07-07

Review 6.  Protein Translation and Signaling in Human Eosinophils.

Authors:  Stephane Esnault; Zhong-Jian Shen; James S Malter
Journal:  Front Med (Lausanne)       Date:  2017-09-19

7.  Transcriptome networks identify mechanisms of viral and nonviral asthma exacerbations in children.

Authors:  Matthew C Altman; Michelle A Gill; Elizabeth Whalen; Denise C Babineau; Baomei Shao; Andrew H Liu; Brett Jepson; Rebecca S Gruchalla; George T O'Connor; Jacqueline A Pongracic; Carolyn M Kercsmar; Gurjit K Khurana Hershey; Edward M Zoratti; Christine C Johnson; Stephen J Teach; Meyer Kattan; Leonard B Bacharier; Avraham Beigelman; Steve M Sigelman; Scott Presnell; James E Gern; Peter J Gergen; Lisa M Wheatley; Alkis Togias; William W Busse; Daniel J Jackson
Journal:  Nat Immunol       Date:  2019-04-08       Impact factor: 25.606

Review 8.  CD9 Tetraspanin: A New Pathway for the Regulation of Inflammation?

Authors:  Carole Brosseau; Luc Colas; Antoine Magnan; Sophie Brouard
Journal:  Front Immunol       Date:  2018-10-09       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.